Bank Of Montreal Genmab A/S Transaction History

Bank Of Montreal

$197 Billion
Q2 2024

A detailed history of Bank Of Montreal transactions in Genmab A/S stock. As of the latest transaction made, Bank Of Montreal holds 76,987 shares of GMAB stock, worth $1.72 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

76,987

Previous 78,790 2.29%

Holding current value

$1.72 Million

Previous $2.36 Million 17.91%

% of portfolio

0.0%

Previous 0.0%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$25.13 - $30.27 $45,309 - $54,576	-1,803 Reduced 2.29%	76,987 $1.93 Million
Q1 2024 May 13, 2024	BUY	$26.43 - $32.77 $396,053 - $491,058	14,985 Added 23.49%	78,790 $2.36 Million
Q4 2023 Feb 08, 2024	SELL	$27.94 - $35.44 $240,367 - $304,890	-8,603 Reduced 11.88%	63,805 $2.03 Million
Q3 2023 Nov 01, 2023	BUY	$35.27 - $42.24 $1.38 Million - $1.66 Million	39,246 Added 118.35%	72,408 $2.55 Million
Q2 2023 Aug 02, 2023	SELL	$37.4 - $42.94 $92,265 - $105,932	-2,467 Reduced 6.92%	33,162 $1.26 Million
Q1 2023 Jun 13, 2024	SELL	$34.88 - $43.22 $1.57 Million - $1.95 Million	-45,140 Reduced 57.29%	33,650 $1.27 Million
Q4 2022 Feb 01, 2023	SELL	$33.8 - $47.06 $18,860 - $26,259	-558 Reduced 1.54%	35,629 $1.51 Million
Q3 2022 Nov 10, 2022	BUY	$31.52 - $373.61 $18,439 - $218,561	585 Added 1.64%	36,187 $1.17 Million
Q2 2022 Aug 11, 2022	SELL	$26.83 - $38.57 $19,746 - $28,387	-736 Reduced 2.03%	35,602 $1.15 Million
Q1 2022 May 12, 2022	SELL	$30.95 - $39.68 $83,069 - $106,501	-2,684 Reduced 6.88%	36,338 $1.35 Million
Q4 2021 Feb 11, 2022	BUY	$35.87 - $47.12 $49,213 - $64,648	1,372 Added 3.64%	39,022 $1.57 Million
Q3 2021 Nov 12, 2021	BUY	$41.55 - $48.72 $55,552 - $65,138	1,337 Added 3.68%	37,650 $1.62 Million
Q2 2021 Aug 12, 2021	BUY	$32.88 - $44.57 $1.19 Million - $1.62 Million	36,313 New	36,313 $1.48 Million

Others Institutions Holding GMAB

# of Institutions

235

Shares Held

48.6M

Call Options Held

6.8K

Put Options Held

27.6K

View Full List

About GENMAB A/S

Ticker GMAB
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 658,292,992
Market Cap $14.7B
Description
Genmab A/S develops antibody therapeutics for the treatment of cancer and other diseases primarily in Denmark. The company markets DARZALEX, a human monoclonal antibody for the treatment of patients with multiple myeloma (MM); teprotumumab for the treatment of thyroid eye disease; ofatumurnab, a human monoclonal antibody to treat chronic lymphoc...

More about GMAB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of Montreal , based on Form 13F filings with the SEC.

News

Stay updated on Bank Of Montreal with notifications on news.

Account